GlassScriptPhysician profile
Lorien S Lamar
NPI 1699724625
$4,840.32
in general payments reported to CMS, 2019-2025
20 companies · $968 in 2025
The $968 reported for 2025 was more than what 83% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $592 · 2022: $1,408 · 2023: $1,204 · 2024: $668 · 2025: $968.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,651 · Education: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,651.42 |
| Education | $188.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,850.18 | 2021-2025 | |
| Janssen Biotech, INC. | $703.22 | 2021-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $533.61 | 2021-2025 | Dupixent |
| Novartis Pharmaceuticals Corporation | $256.02 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $248.92 | 2021-2025 | Winlevi, Absorica Ld, Ilumya |
| Lilly USA, LLC | $221.00 | 2021-2024 | Olumiant, Taltz |
| Almirall LLC | $185.86 | 2021-2023 | Klisyri |
| Galderma Laboratories, L.P. | $176.64 | 2021-2025 | |
| Amgen INC. | $124.46 | 2021 | |
| Ucb, INC. | $110.84 | 2021-2025 | Bimzelx |
| E.R. Squibb & Sons, L.L.C. | $88.87 | 2022-2024 | Sotyktu |
| Genzyme Corporation | $68.24 | 2022-2024 | |
| Leo Pharma INC. | $55.88 | 2021-2024 | Adbry |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $36.74 | 2022-2025 | Cabtreo |
| Organon LLC | $36.49 | 2025 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arcutis Biotherapeutics, INC. | $34.62 | 2024-2025 | Zoryve |
| Incyte Corporation | $32.99 | 2022 | |
| Dermavant Sciences, INC. | $32.61 | 2023-2024 | Vtama |
| Pfizer INC. | $29.84 | 2022-2025 | |
| Epi Health, LLC | $13.29 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lorien Lamar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.